Stock Scorecard



Stock Summary for Becton Dickinson & Company (BDX) - $174.98 as of 5/13/2025 7:08:29 AM EST

Total Score

12 out of 30

Safety Score

64 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for BDX

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for BDX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for BDX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for BDX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for BDX (64 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 9
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 5
Dividend Yield Percentage (Max of 10) 4
Operating Margin (Max of 10) 4
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 5
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for BDX

Tariffs Dim Hologic's 2025 Expectations: Time to Reassess the Stock? 5/12/2025 12:44:00 PM
Generic Drugs Market size is projected to reach USD 594.99 billion by 2031, With growing at a CAGR of 5.0% | The Insight Partners 5/9/2025 2:31:00 PM
Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results 5/9/2025 10:30:00 AM
FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight - Becton Dickinson ( NYSE:BDX ) , Bristol-Myers Squibb ( NYSE:BMY ) 5/6/2025 7:21:00 PM
Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock For Years - Becton Dickinson ( NYSE:BDX ) 5/2/2025 8:33:00 PM
This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Apple ( NASDAQ:AAPL ) , Airbnb ( NASDAQ:ABNB ) 5/2/2025 5:50:00 PM
Becton Dickinson ( BDX ) technical analysis - Becton Dickinson ( NYSE:BDX ) 5/2/2025 1:54:00 PM
BD Stock Falls in Pre-Market Despite Q2 Earnings Beat, Margins Down 5/1/2025 3:39:00 PM
Potential Tariff Bites Into Becton Dickinson 2025 Profit Outlook, Company Will Invest $2.5 Billion To Boost US Manufacturing - Becton Dickinson ( NYSE:BDX ) 5/1/2025 3:03:00 PM
Becton Dickinson ( BDX ) Q2 Earnings Top Estimates 5/1/2025 11:45:00 AM

Financial Details for BDX

Company Overview

Ticker BDX
Company Name Becton Dickinson & Company
Country USA
Description Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
Sector Name LIFE SCIENCES
Industry Name SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Most Recent Quarter 3/31/2025
Next Earnings Date 7/31/2025

Stock Price History

Last Day Price 174.98
Price 4 Years Ago 233.41
Last Day Price Updated 5/13/2025 7:08:29 AM EST
Last Day Volume 4,133,688
Average Daily Volume 3,428,199
52-Week High 250.85
52-Week Low 163.33
Last Price to 52 Week Low 7.13%

Valuation Measures

Trailing PE 32.41
Industry PE 48.91
Sector PE 47.92
5-Year Average PE 21.49
Free Cash Flow Ratio 75.10
Industry Free Cash Flow Ratio 39.21
Sector Free Cash Flow Ratio 30.82
Current Ratio Most Recent Quarter 1.13
Total Cash Per Share 2.33
Book Value Per Share Most Recent Quarter 88.07
Price to Book Ratio 1.90
Industry Price to Book Ratio 5.21
Sector Price to Book Ratio 27.83
Price to Sales Ratio Twelve Trailing Months 2.30
Industry Price to Sales Ratio Twelve Trailing Months 4.27
Sector Price to Sales Ratio Twelve Trailing Months 25.47
Analyst Buy Ratings 8
Analyst Strong Buy Ratings 5

Share Statistics

Total Shares Outstanding 286,607,000
Market Capitalization 50,150,492,860
Institutional Ownership N/A

Dividends

Ex-Dividend Date 6/9/2025
Previous Dividend Amount 1.0400
Current Dividend Amount 1.0400
Total Years Dividend Increasing Dividend Aristocrat - Increasing for 40 Years
Trailing Annual Dividend Rate 3.98
Trailing Annual Dividend Yield 2.37%
Forward Annual Dividend Rate 4.16
Forward Annual Dividend Yield 2.48%
5-Year Dividend Payments Count 21
3-Year Average Dividend Yield 1.72%
5-Year Average Dividend Yield 1.53%
1-Year Dividend Growth Rate Percentage 6.94%
3-Year Dividend Growth Rate Percentage 3.41%
5-Year Dividend Growth Rate Percentage 5.48%
All-Time Dividend Growth Rate Percentage 10.58%
Dividend Payout Ratio 77.13%

Income Statement

Quarterly Earnings Growth YOY -42.20%
Annual Earnings Growth 14.89%
Reported EPS 12 Trailing Months 5.16
Reported EPS Past Year 6.78
Reported EPS Prior Year 13.16
Net Income Twelve Trailing Months 1,498,000,000
Net Income Past Year 1,705,000,000
Net Income Prior Year 1,484,000,000
Quarterly Revenue Growth YOY 4.50%
5-Year Revenue Growth 3.14%
Operating Margin Twelve Trailing Months 16.00%

Balance Sheet

Total Cash Most Recent Quarter 667,000,000
Total Cash Past Year 1,717,000,000
Total Cash Prior Year 1,416,000,000
Net Cash Position Most Recent Quarter -16,999,000,000
Net Cash Position Past Year -16,223,000,000
Long Term Debt Past Year 17,940,000,000
Long Term Debt Prior Year 14,738,000,000
Total Debt Most Recent Quarter 17,666,000,000
Equity to Debt Ratio Past Year 0.59
Equity to Debt Ratio Most Recent Quarter 0.59
Total Stockholder Equity Past Year 25,889,000,000
Total Stockholder Equity Prior Year 25,796,000,000
Total Stockholder Equity Most Recent Quarter 25,241,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 2,590,000,000
Free Cash Flow Per Share Twelve Trailing Months 9.04
Free Cash Flow Past Year 3,073,000,000
Free Cash Flow Prior Year 2,115,000,000

Options

Put/Call Ratio 0.31
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -12.56
MACD Signal -10.54
20-Day Bollinger Lower Band 170.66
20-Day Bollinger Middle Band 216.25
20-Day Bollinger Upper Band 261.85
Beta 0.34
RSI 28.01
50-Day SMA 226.25
150-Day SMA 235.74
200-Day SMA 236.00

System

Modified 5/12/2025 6:42:26 PM EST